Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2B |
| 2 |
Penumbra
PEN
|
+$150M |
| 3 |
FPS
Forgent Power Solutions
FPS
|
+$54.2M |
| 4 |
CRH
CRH
|
+$52.3M |
| 5 |
Meta Platforms (Facebook)
META
|
+$52.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$236M |
| 2 |
Broadcom
AVGO
|
+$182M |
| 3 |
Walmart Inc
WMT
|
+$158M |
| 4 |
NVIDIA
NVDA
|
+$126M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$103M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.43% |
| 2 | Technology | 14.31% |
| 3 | Healthcare | 10.51% |
| 4 | Industrials | 7.72% |
| 5 | Financials | 6.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Acadia Pharmaceuticals
ACAD
$5.04B
| – | – |
-76,183
| Closed | -$2.03M |
|
1502
Acco Brands
ACCO
$390M
| – | – |
-10,041
| Closed | -$37.5K |
|
1503
Archer Aviation
ACHR
$4.66B
| – | – |
-507,779
| Closed | -$3.82M |
|
1504
American Coastal Insurance
ACIC
$441M
| – | – |
-31,256
| Closed | -$395K |
|
1505
Aecom
ACM
$8.36B
| – | – |
-58,407
| Closed | -$5.57M |
|
1506
Enact Holdings
ACT
$6.86B
| – | – |
-50,178
| Closed | -$1.99M |
|
1507
Autodesk
ADSK
$53.8B
| – | – |
-38,522
| Closed | -$11.4M |
|
1508
Addus HomeCare
ADUS
$2.27B
| – | – |
-5,009
| Closed | -$538K |
|
1509
Aegon
AEG
$13.6B
| – | – |
-20,940
| Closed | -$161K |
|
1510
AerCap
AER
$23.1B
| – | – |
-61,765
| Closed | -$8.88M |
|
1511
AES
AES
$10.5B
| – | – |
-763,518
| Closed | -$10.9M |
|
1512
American Financial Group
AFG
$12B
| – | – |
-42,144
| Closed | -$5.76M |
|
|
AGEN
1513
Agenus
AGEN
$348M
| – | – |
-47,461
| Closed | -$149K |
|
1514
Agios Pharmaceuticals
AGIO
$1.96B
| – | – |
-71,146
| Closed | -$1.94M |
|
1515
American International
AIG
$40.6B
| – | – |
-215,187
| Closed | -$18.4M |
|
|
AIV
1516
Aimco
AIV
$382M
| – | – |
-252,553
| Closed | -$1.5M |
|
1517
Allegiant Air
ALGT
$2.25B
| – | – |
-22,403
| Closed | -$1.91M |
|
1518
Alignment Healthcare
ALHC
$2.81B
| – | – |
-381,202
| Closed | -$7.53M |
|
1519
Alight
ALIT
$392M
| – | – |
-2,736
| Closed | -$107K |
|
1520
Alkami Technology
ALKT
$2.21B
| – | – |
-85,403
| Closed | -$1.97M |
|
1521
Allegion
ALLE
$14.1B
| – | – |
-13,072
| Closed | -$2.08M |
|
|
ALX
1522
Alexander's
ALX
$1.36B
| – | – |
-6,103
| Closed | -$1.33M |
|
1523
CALL
Applied Materials
AMAT
$379B
| – | – |
-1,200
| Closed | -$309K |
|
|
OSG
1524
Octave Specialty Group
OSG
$207M
| – | – |
-109,765
| Closed | -$854K |
|
1525
Affiliated Managers Group
AMG
$9.25B
| – | – |
-37,845
| Closed | -$10.9M |
|
Similar funds
Michael Gelband's Q1 2026 Portfolio in Review
As of Q1 2026, Michael Gelband held 2,232 positions worth $12.6B, down 1.2% from $12.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Michael Gelband's Q1 2026 filing shows 759 new, 357 increased, 372 reduced and 737 closed positions. Its largest new stake was Forgent Power Solutions: 1,627,490 shares worth $47.6M. The largest sale was Apple, an estimated $236M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 6.5% a quarter earlier, followed by Technology and Healthcare.
- Michael Gelband's largest Q1 2026 buy was Forgent Power Solutions: 1,627,490 shares worth $47.6M.
- Michael Gelband added most to Tesla in Q1 2026, an estimated $2B increase.
- Michael Gelband's biggest Q1 2026 reduction was Apple, cutting an estimated $236M.
- Michael Gelband fully exited Walmart Inc in Q1 2026, selling an estimated $158M.
- Michael Gelband's ten largest holdings make up 35% of its $12.6B portfolio in Q1 2026.
- Michael Gelband opened 759 new positions and closed 737 in Q1 2026.
- Michael Gelband's portfolio value fell 1.2% quarter-over-quarter to $12.6B.
Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.